Population Pharmacokinetics and Exposure‐Response Relationships of Astegolimab in Patients With Severe Asthma-Reference-Cited by-同舟云学术

Population Pharmacokinetics and Exposure‐Response Relationships of Astegolimab in Patients With Severe Asthma

Published:2022-02-09 Issue: Volume: Page:
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:The Journal of Clinical Pharma

Author:

Kotani Naoki¹²^ORCID,Dolton Michael¹,Svensson Robin J.³,Ribbing Jakob³,Friberg Lena E.³⁴,Vadhavkar Shweta¹,Cheung Dorothy¹,Staton Tracy¹,Sperinde Gizette¹,Jin Jin¹,Putnam Wendy S.¹,Quartino Angelica¹

Affiliation:

1. Genentech Inc. South San Francisco California USA

2. Chugai Pharmaceutical Co. Ltd. Tokyo Japan

3. Pharmetheus Uppsala Sweden

4. Department of Pharmacy Uppsala University Uppsala Sweden

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcph.2021

Reference21 articles.

1. Global strategy for asthma management and prevention 2020. Global Initiative for Asthma.www.ginasthma.org. Accessed November 19 2021.

2. Global asthma prevalence in adults: findings from the cross-sectional world health survey

3. Uncontrolled asthma: A review of the prevalence, disease burden and options for treatment

4. High Blood Eosinophil Count Is a Risk Factor for Future Asthma Exacerbations in Adult Persistent Asthma

5. Factors Associated With the Control of Severe Asthma

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population Pharmacokinetic Modeling and Exposure–Efficacy and Body Weight–Response Analyses for Tezepelumab in Patients With Severe, Uncontrolled Asthma;The Journal of Clinical Pharmacology;2024-04-17

2. Relationship between serum IgA levels and low percentage forced expiratory volume in the first second in asthma;Journal of Asthma;2024-03-08